After adjusting for time (weeks post-infection), dose, and CD45+ cells, higher viral dose (105) was positively associated with greater plasma HIV-1 titres (adjusted β 1.98, 95% CI: 0.19–3.78; P = 0.032) than the lower viral dose (103). Here, PTPRC is linked to infection.